| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |